These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17253306)

  • 1. MEKC analysis of different Echinacea species.
    Pietta P; Mauri P; Bauer R
    Planta Med; 1998 Oct; 64(7):649-52. PubMed ID: 17253306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous analysis of alkamides and caffeic acid derivatives for the identification of Echinacea purpurea, Echinacea angustifolia, Echinacea pallida and Parthenium integrifolium roots.
    Laasonen M; Wennberg T; Harmia-Pulkkinen T; Vuorela H
    Planta Med; 2002 Jun; 68(6):572-4. PubMed ID: 12094312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.
    Barnes J; Anderson LA; Gibbons S; Phillipson JD
    J Pharm Pharmacol; 2005 Aug; 57(8):929-54. PubMed ID: 16102249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of alkamides from Echinacea purpurea extracts by cyclodextrin-modified micellar electrokinetic chromatography.
    Gotti R; Fiori J; Hudaib M; Cavrini V
    Electrophoresis; 2002 Sep; 23(17):3084-92. PubMed ID: 12207319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low-density lipoproteins.
    Dalby-Brown L; Barsett H; Landbo AK; Meyer AS; Mølgaard P
    J Agric Food Chem; 2005 Nov; 53(24):9413-23. PubMed ID: 16302756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Echinacea drugs--effects and active ingredients].
    Bauer R
    Z Arztl Fortbild (Jena); 1996 Apr; 90(2):111-5. PubMed ID: 8686333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution method for regulatory control of Echinacea species in Nutraceuticals by CD-MEKC.
    Bensalem M; Hartwell E; Hartwell S; Hill H; Fell AF
    J Pharm Biomed Anal; 2005 Apr; 37(5):885-91. PubMed ID: 15862662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Echinacea species and detection of possible adulterations by RAPD analysis.
    Wolf HT; Zündorf I; Winckler T; Bauer R; Dingermann T
    Planta Med; 1999 Dec; 65(8):773-4. PubMed ID: 17260303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of phenolic constituents in Echinacea purpurea grown in China.
    Liu YC; Zeng JG; Chen B; Yao SZ
    Planta Med; 2007 Dec; 73(15):1600-5. PubMed ID: 18058611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability in the composition of anti-oxidant compounds in Echinacea species by HPLC.
    Pellati F; Benvenuti S; Melegari M; Lasseigne T
    Phytochem Anal; 2005; 16(2):77-85. PubMed ID: 15881113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic characterization of the three medicinal Echinacea species using RAPD analysis.
    Nieri P; Adinolfi B; Morelli I; Breschi MC; Simoni G; Martinotti E
    Planta Med; 2003 Jul; 69(7):685-6. PubMed ID: 12898432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLC and HPLC analysis of Echinacea pallida and E. angustifolia roots.
    Bauer R; Khan IA; Wagner H
    Planta Med; 1988 Oct; 54(5):426-30. PubMed ID: 17265305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of phenolic compounds and radical scavenging activity of Echinacea spp.
    Pellati F; Benvenuti S; Magro L; Melegari M; Soragni F
    J Pharm Biomed Anal; 2004 Apr; 35(2):289-301. PubMed ID: 15063463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence characterized amplified region (SCAR) analysis on DNA from the three medicinal Echinacea species.
    Adinolfi B; Chicca A; Martinotti E; Breschi MC; Nieri P
    Fitoterapia; 2007 Jan; 78(1):43-5. PubMed ID: 17067760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotechnological production of caffeic acid derivatives from cell and organ cultures of Echinacea species.
    Murthy HN; Kim YS; Park SY; Paek KY
    Appl Microbiol Biotechnol; 2014 Sep; 98(18):7707-17. PubMed ID: 25077780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic effects of Echinacea root hexanic extracts on human cancer cell lines.
    Chicca A; Adinolfi B; Martinotti E; Fogli S; Breschi MC; Pellati F; Benvenuti S; Nieri P
    J Ethnopharmacol; 2007 Mar; 110(1):148-53. PubMed ID: 17052874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic relationships and diversity of commercially relevant Echinacea species.
    Kapteyn J; Goldsbrough B; Simon E
    Theor Appl Genet; 2002 Aug; 105(2-3):369-376. PubMed ID: 12582540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-Glycoprotein inhibitory activity of lipophilic constituents of Echinacea pallida roots in a human proximal tubular cell line.
    Romiti N; Pellati F; Nieri P; Benvenuti S; Adinolfi B; Chieli E
    Planta Med; 2008 Feb; 74(3):264-6. PubMed ID: 18425719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of alkamides and caffeic acid derivatives from Echinacea simulata and E. paradoxa roots.
    Bauer R; Foster S
    Planta Med; 1991 Oct; 57(5):447-9. PubMed ID: 1798799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLC and HPLC Analysis of Alkamides in Echinacea Drugs1,2.
    Bauer R; Remiger P
    Planta Med; 1989 Aug; 55(4):367-71. PubMed ID: 17262436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.